House committee set to subpoena AbbVie over Humira pricing 03-Sep-2020 By Nick Taylor The House Committee on Oversight and Reform plans to subpoena AbbVie over pricing of Humira and Imbruvica, alleging the company repeatedly failed to comply with requests.